retatrutide mechanism triple agonist gip glp-1 glucagon 🎙️ NEW EPISODE: Retatrutide—The *Not licensed* Will this replace the current in the market. This triple receptor agonist (GIP/ GLP-1/glucagon) is showing unprecedented results in weight loss trials, outperforming current 🎙️ NEW EPISODE: Retatrutide—The Triple

Studies show that patients who reach higher therapeutic doses (0.52.4 mg weekly for semaglutide) achieve greater weight loss and longer-lasting results than those who stop at lower doses

J Pineal Res 36:155164 Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ (2010) Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1)

CLICK HERE TO GET Free Masterclass: Freedom From Food Noise: *** Get Connected with Elizabeth McGann: Coaching Website: Instagram: Facebook: LinkedIn: X/Twitter: *** Learn more about Shelley Carling: Instagram: 43m - Feb 10, 2026 9 GLP-1 Truths I Wish I'd Known Sooner (From a 52-Year-Old Nutritionist) If you've been doing everything "right" and your body still feels stuckThis episode is for you

Real Patient Experiences with GLP-1 Complications Some patients celebrate remarkable results

This process removes water and locks the molecule into a stable, powdered form for shipping and storage

prescribe glucagon in people at risk for severe hypoglycaemia